Renaissance Technologies (RenTech)'s INMB Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 17,000 shares of INmune Bio Inc. (INMB) worth $19,210, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in INMB, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 107,200 shares. Largest reduction occurred in Q1 2025, reducing 185,800 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s INmune Bio (INMB) Holding Value Over Time
Track share changes against reported price movement
Quarterly INmune Bio (INMB) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +17,000 | New Buy | 17,000 | $1.13 |
| Q1 2025 | -185,800 | Sold Out | 0 | $0.00 |
| Q4 2024 | +78,600 | Add 73.32% | 185,800 | $4.67 |
| Q3 2024 | +107,200 | New Buy | 107,200 | $5.39 |
| Q3 2023 | -20,000 | Sold Out | 0 | $0.00 |
| Q2 2023 | -14,800 | Reduce 42.53% | 20,000 | $0.01 |
| Q1 2023 | +34,800 | New Buy | 34,800 | $0.01 |
| Q3 2022 | -32,100 | Sold Out | 0 | $0.00 |
| Q2 2022 | +32,100 | New Buy | 32,100 | $8.85 |
| Q4 2020 | -40,000 | Sold Out | 0 | $0.00 |
| Q3 2020 | +40,000 | New Buy | 40,000 | $10.30 |
Renaissance Technologies (RenTech)'s INmune Bio Investment FAQs
Renaissance Technologies (RenTech) first purchased INmune Bio Inc. (INMB) in Q3 2020, acquiring 40,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held INmune Bio Inc. (INMB) for 11 quarters since Q3 2020.
Renaissance Technologies (RenTech)'s largest addition to INmune Bio Inc. (INMB) was in Q3 2024, adding 107,200 shares worth $577,808.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 17,000 shares of INmune Bio Inc. (INMB), valued at approximately $19,210.
As of the Q1 2026 filing, INmune Bio Inc. (INMB) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in INmune Bio Inc. (INMB) was 185,800 shares, as reported at the end of Q4 2024.